Skip to main content
Premium Trial:

Request an Annual Quote

'Course Correction to Compete'

FierceBiotech's Ryan McBride and John Carroll received more than 130 nominations for their 2011 Women in Biotech feature. "True to our mission of providing readers the top news in biotech, many of the honorees here are women who drove some of the big stories we covered this year," they write. These women are "rallying scientists at young startups, gearing up for important late-stage trials or leading research of serious health concerns such as HIV," among other endeavors, McBride and Carroll add. The honorees include the Fred Hutchinson Cancer Research Center's Julie Overbaugh, lauded for her work on the immunological factors that could prevent HIV infections.

Eleven Biotherapeutics' Abbie Celniker tells FierceBiotech that "the potential interesting little extra that you get from speaking to some of the women in biotech is we've probably been challenged with thinking a little bit more about how to cultivate our careers. … As a result, we can be a tiny bit more self-reflective because we've had to do lots of course correction to make sure we could compete in the days when it was more predominately male."

Full profiles for each of the 10 women honored appear here.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.